Get the app!
Back to Trades

Gupta Shalabh K.

CEODirectorCIK 0001864917

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Gupta Shalabh K., CEO, Director, accounts for 2 disclosed filings worth $1.5M, all concentrated in Unicycive Therapeutics, Inc. (UNCY), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jun 15UNCY
Unicycive Therapeutics, Inc.
Gupta Shalabh K.CEO, DirectorAward$0
Jul 30UNCY
Unicycive Therapeutics, Inc.
Gupta Shalabh K.CEO, DirectorAward$1.5M

2 filings